Streetbeat News

Price Targets

CBAY

UBS has maintained its Buy rating for CymaBay Therapeutics (NASDAQ:CBAY) and increased its price target from $18.00 to $25.00. This new target price represents a 62.76% increase from the current share price. CymaBay Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for patients with liver and other chronic diseases.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 5:00 pm

GD

Berenberg has maintained its Market Perform rating for General Dynamics (NYSE:GD) and raised its price target from $254.00 to $258.00. The new price target represents a 17.81% increase from the current share price. General Dynamics is a defense contractor and business jet manufacturer with segments in aerospace, marine, combat systems, and technologies.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 5:00 pm

APP

BTIG has maintained its Buy rating for AppLovin (NASDAQ:APP) and increased its price target from $40.00 to $46.00. AppLovin's shares are currently trading up 1.44% over the last 24 hours, at $38.75 per share. A move to $46.00 would account for a 18.71% increase from the current share price.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 5:00 pm

CSCO

Unusual options activity has been observed for Cisco Systems (NASDAQ:CSCO), with a split sentiment of 50% bullish and 50% bearish among big-money traders. The activity includes 6 puts and 6 calls, with total amounts of $249,057 and $352,810 respectively. Whales have been targeting a price range from $52.5 to $55.0 for Cisco Systems over the last 3 months. The current price of CSCO is down -1.28% at $52.8. Tigress Financial maintains a Buy rating on Cisco Systems with a price target of $76, while B of A Securities maintains a Neutral rating with a price target of $60.

Portfolio Pulse from Benzinga Insights

September 26, 2023 | 4:45 pm

CHRS

Truist Securities analyst Robyn Karnauskas has reiterated a 'Buy' rating on Coherus BioSciences (NASDAQ:CHRS) and maintained a $20 price target.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 4:20 pm

NDSN

Nordson Corporation's shares are trading lower after Jefferies downgraded the stock from Buy to Hold and lowered its price target from $260 to $240.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 4:19 pm

BKNG

Argus Research analyst John Staszak has reiterated a 'Buy' rating on Booking Holdings (NASDAQ:BKNG) and maintained a price target of $3677.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 4:18 pm

KFY

Truist Securities analyst Tobey Sommer has reiterated a 'Buy' rating on Korn Ferry (NYSE:KFY) and maintained a price target of $65.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 4:15 pm

AMC

Citigroup analyst Jason Bazinet has maintained a 'Sell' rating on AMC Enter Hldgs (NYSE:AMC) and lowered the price target from $15.5 to $4.75.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 4:14 pm

OMCL

Wells Fargo analyst Stan Berenshteyn has maintained an Underweight rating on Omnicell (NASDAQ:OMCL) and lowered the price target from $56 to $39.

Portfolio Pulse from Benzinga Newsdesk

September 26, 2023 | 4:13 pm